Legal & General Group Plc - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$4,000
-94.2%
38,418
-5.5%
0.00%
Q3 2018$69,000
-2.8%
40,6340.0%0.00%
Q2 2018$71,000
-15.5%
40,634
-12.0%
0.00%
Q1 2018$84,000
-39.6%
46,187
-25.3%
0.00%
Q4 2017$139,000
-21.0%
61,803
+0.2%
0.00%
Q3 2017$176,000
-29.3%
61,701
+9.5%
0.00%
Q2 2017$249,000
+7.8%
56,358
+13.9%
0.00%
Q1 2017$231,000
-13.2%
49,476
+12.2%
0.00%
Q4 2016$266,000
+91.4%
44,109
+68.1%
0.00%
Q3 2016$139,000
+27.5%
26,236
-10.6%
0.00%
Q2 2016$109,000
+118.0%
29,343
+60.0%
0.00%
Q1 2016$50,000
-51.9%
18,3420.0%0.00%
Q4 2015$104,000
+4.0%
18,3420.0%0.00%
Q3 2015$100,000
-32.4%
18,3420.0%0.00%
Q2 2015$148,000
+82.7%
18,3420.0%0.00%
Q1 2015$81,000
+44.6%
18,3420.0%0.00%
Q4 2014$56,000
+7.7%
18,3420.0%0.00%
Q3 2014$52,00018,3420.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,273,509$9,493,0001.85%
Trellus Management Company, LLC 362,500$1,051,0001.44%
Paulson & Co. 24,062,368$69,781,0001.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 971,922$2,799,0001.09%
Asymmetry Capital Management, L.P. 271,102$786,0000.91%
Cheyne Capital Management (UK) LLP 651,500$1,880,0000.68%
Hikari Power Ltd 1,500,000$4,350,0000.56%
Orbimed Advisors 13,621,443$39,502,0000.38%
CARL DOMINO INC 83,000$241,0000.29%
KNOTT DAVID M 158,400$459,0000.20%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders